Metastatic Castration-resistant Prostate Cancer
1 competing product in clinical development for Metastatic Castration-resistant Prostate Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| SRF617 + etrumadenant + zimberelimab | Coherus BioSciences | Phase 2 | Terminated | 44 |